Why the study?
What are the real-world outcomes and recommended dosages of NOACs compared to warfarin in Korean patients with atrial fibrillation?
What are the real-world outcomes and recommended dosages of NOACs compared to warfarin in Korean patients with atrial fibrillation?
This review provides tailored NOAC dosage recommendations for Korean patients with atrial fibrillation based on real-world evidence.
No takes yet. Share an insight, caveat, or question.
May guide NOAC dosing in Korean AF patients; leaves open need for prospective validation before practice change.
Boyoung Joung (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: